tbuckley/cabot-search huggingface dataset:
EARLY CHANGES IN CARDIOVASCULAR BIOMARKERS WITH CONTEMPORARY THORACIC RADIATION THERAPY FOR BREAST CANCER, LUNG CANCER, AND LYMPHOMA
Authors: Biniyam G. Demissei, Gary Freedman, Steven J. Feigenberg, John P. Plastaras, Amit Maity, Amanda M. Smith, Caitlin McDonald, Karyn Sheline, Charles B. Simone, Lillie Lin, Joseph Carver, Peter Liu, Liyong Zhang, Justin Bekelman, Bonnie Ky
Journal: Journal of the American College of Cardiology (2019)
GDF-15 IS ASSOCIATED WITH FUNCTIONAL CAPACITY &amp; VENTRICULAR DYSFUNCTION IN PATIENTS WITH MODERATE TO SEVERE AORTIC STENOSIS &amp; PRESERVED EJECTION FRACTION
Authors: Lauren Basmadjian, François Simard, Nadia Bouabdallaoui, Eileen O'Meara, Normand Racine, Michel White, Anique Ducharme, Martin Sirois, Anita Asgar, Reda Ibrahim, Jean-François Dorval, Raoul Bonan, Raymond Cartier, Jessica Forcillo, Ismail El-Hamamsy, Christine Henri
Journal: Journal of the American College of Cardiology (2019)
NOVEL BIOMARKERS OF CORONARY ARTERY CALCIUM INCIDENCE OR PROGRESSION: INSIGHTS FROM THE DALLAS HEART STUDY
Authors: Alon Eisen, Ran Kornowski, Ashraf Hamdan, Yeela Talmor-Barkan, Guy Witberg, Kaivalya Deshpande, Andre Paixao, Colby Ayers, Parag Joshi, Anand Rohatgi, Amit Khera, James de Lemos, Ian Neeland
Journal: Journal of the American College of Cardiology (2019)
Abstract IA27: Tumor suppressor and tumor maintenance genes
Authors: Scott W. Lowe
Journal: Clinical Cancer Research (2018)

Abstract Cancer arises through an evolutionary process whereby normal cells acquire mutations that erode growth controls, leading to the expansion of aberrantly proliferating cells. Such mutations activate oncogenes or inactivate tumor suppressors, each bestowing new capabilities to emerging tumors. Still, cancer is not an inevitable consequence of mutation but is instead kept in check by intrinsic tumor-suppressor programs activated in damaged cells. Accordingly, our laboratory studies such mechanisms in order to reveal key regulatory nodes controlling basic cellular processes and to identify the strategies nature uses to combat cancer. More recently, our interests have expanded to explore the action of tumor maintenance genes---those genes needed to sustain the proliferation and survival of malignant cancer cells---with the goal of identifying cancer vulnerabilities and therapeutic targets. Our approach combines powerful mouse models, genetics, and genomics in a coordinated manner that allows us to study tumor suppressor and tumor maintenance networks in a comprehensive way. Recent efforts to combine these tools towards the production of flexible and accurate mouse models and their subsequent use to identify and characterize tumor suppressor and tumor maintenance genes will be discussed. Citation Format: Scott W. Lowe. Tumor suppressor and tumor maintenance genes [abstract]. In: Proceedings of the AACR International Conference held in cooperation with the Latin American Cooperative Oncology Group (LACOG) on Translational Cancer Medicine; May 4-6, 2017; São Paulo, Brazil. Philadelphia (PA): AACR; Clin Cancer Res 2018;24(1_Suppl):Abstract nr IA27.
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth
Authors: Troy E. Messick, Garry R. Smith, Samantha S. Soldan, Mark E. McDonnell, Julianna S. Deakyne, Kimberly A. Malecka, Lois Tolvinski, A. Pieter J. van den Heuvel, Bai-Wei Gu, Joel A. Cassel, Donna H. Tran, Benjamin R. Wassermann, Yan Zhang, Venkata Velvadapu, Edward R. Zartler, Pierre Busson, Allen B. Reitz, Paul M. Lieberman
Journal: Science Translational Medicine (2019)

EBNA1 inhibitors developed by fragment-based drug design block EBNA1 DNA binding and EBV-dependent tumor cell growth in vivo.
State gun laws, gun ownership, and mass shootings in the US: cross sectional time series
Authors: Paul M Reeping, Magdalena Cerdá, Bindu Kalesan, Douglas J Wiebe, Sandro Galea, Charles C Branas
Journal: BMJ (2019)

Abstract Objective To determine whether restrictiveness-permissiveness of state gun laws or gun ownership are associated with mass shootings in the US. Design Cross sectional time series. Setting and population US gun owners from 1998-2015. Exposure An annual rating between 0 (completely restrictive) and 100 (completely permissive) for the gun laws of all 50 states taken from a reference guide for gun owners traveling between states from 1998 to 2015. Gun ownership was estimated annually as the percentage of suicides committed with firearms in each state. Main outcome measure Mass shootings were defined as independent events in which four or more people were killed by a firearm. Data from the Federal Bureau of Investigation’s Uniform Crime Reporting System from 1998-2015 were used to calculate annual rates of mass shootings in each state. Mass shooting events and rates were further separated into those where the victims were immediate family members or partners (domestic) and those where the victims had other relationships with the perpetrator (non-domestic). Results Fully adjusted regression analyses showed that a 10 unit increase in state gun law permissiveness was associated with a significant 11.5% (95% confidence interval 4.2% to 19.3%, P=0.002) higher rate of mass shootings. A 10% increase in state gun ownership was associated with a significant 35.1% (12.7% to 62.7%, P=0.001) higher rate of mass shootings. Partially adjusted regression analyses produced similar results, as did analyses restricted to domestic and non-domestic mass shootings. Conclusions States with more permissive gun laws and greater gun ownership had higher rates of mass shootings, and a growing divide appears to be emerging between restrictive and permissive states.
Molecular Signature of Megakaryocyte-Erythroid Progenitors Reveals Role of Cell Cycle in Fate Specification
Authors: Yi-Chien Lu, Diane S. Krause, Juliana Xavier-Ferrucio, Lin Wang, Nathan Salomonis, Kashish Chetal, Bruce J. Aronow, Chad Sanada, Meenakshi Venkatasubramanian
Journal: Blood (2018)
Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2 Mutation Detection and Monitoring
Authors: Sophie Broutin, Francois Lemonnier, Aurélie Dupuy, Julia Delahousse, Virginie Fataccioli, Vincent Ribrag, Violaine Safar, Laura Pelletier, Cyrielle Robe, Herve Tilly, Anne Ségolène Cottereau, Céline Bossard, Laurence de Leval, Marie-Helene Delfau, Corinne Haioun, Angelo Paci, Philippe Gaulard
Journal: Blood (2018)
USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF
Authors: Erika M. Giblin, Kirkwood Adams, Xiaojuan Mi, Gregg Fonarow, Puza Sharma, Nancy Albert, Javed Butler, Adam DeVore, Carol Duffy, Adrian Hernandez, Kevin McCague, John A. Spertus, Laine Thomas, Fredonia Williams, J. Herbert Patterson
Journal: Journal of the American College of Cardiology (2019)
VENTRICULAR PACING ENTIRELY THROUGH THE CORONARY SINUS AFTER SURGICAL TRICUSPID VALVE
Authors: Chin Lee, Sati Patel, Khuyen Do, Kenneth Kita, Steven Carlson, Mary Huntsinger, Jacqueline Schwartz, Philip Chang, Tomas Konecny, Rahul Doshi
Journal: Journal of the American College of Cardiology (2019)
The Effect on Blood Use after Adopting Single-Unit Policy and Restrictive Transfusion Trigger in a Hematology Unit: The Ensure Study
Authors: Ka Lok Luke Chan, Vivien W M Mak, Edmond P H Choi, Ellen L M Yu, Grace W N Lau, Lydia W B Ho, Kevin C H Kwok, Sandy S K Ho, Kate F S Leung, Michael L G Wong, Harold K K Lee
Journal: Blood (2018)
Studies Made by Simulating Systole at Necropsy
Authors: ISAAC STARR
Journal: Circulation (1958)

The background of basic conceptions underlying this paper is familiar to everyone by experience. The powerful automobile, when the light turns from red to green, can make a "jack-rabbit start" which leaves the less powerful cars far behind. If the engine of the big car is weakened, as by a cylinder gone dead, it can still do 50 miles per hour on the parkway and get you to your destination, but the jack-rabbit start is no longer possible. The first sign of weakness manifests itself more conspicuously in differences in acceleration than in differences in speed or in the distance that can be traveled; indeed the effect on acceleration may be the only manifestation of weakness. There is every reason to expect that this analogy would hold for the cardiac performance also and that the first sign of a weakening myocardium might well manifest itself by a change in acceleration of the ejected blood. This paper is chiefly concerned with the development of a simple method, available to clinicians, which would aid in the detection of changes in the acceleration of the aortic blood. This opportunity has also been used to answer certain criticisms of our previously published work, some, we believe, due to misunderstanding of the mathematical background of statistical procedures, and others due to a frank difference of opinion concerning the accuracy of the Fick method used to test the results secured by one of our formulas published previously.
PROFOUND ANEMIA, ACUTE KIDNEY INJURY AND “HEMATURIA” FOLLOWING PERIPHERAL ANGIOPLASTY AND STENTING: WHAT IS YOUR DIFFERENTIAL DIAGNOSIS?
Authors: Muhammad W. Choudhry, Murtaza Mazhar, Fawad Virk, Haider Alwash, Mohit Sharma, Loui Rejjal, Umamahesh Rangasetty
Journal: Journal of the American College of Cardiology (2019)
PROGNOSTIC IMPACT OF FUNCTIONAL MITRAL REGURGITATION IN PATIENTS WITH NON-ISCHEMIC CARDIOMYOPATHY: ASSOCIATION OF MYOCARDIAL FIBROSIS AND LEFT VENTRICULAR REMODELING
Authors: Nishant Shah, Shailee Shah, Kimi Sato, Sophia Downey, Scott Flamm, Wai Hong Tang, Leslie Cho, Brian Griffin, Deborah Kwon
Journal: Journal of the American College of Cardiology (2019)
HEART FAILURE-EXACERBATING MEDICATION USE IS COMMON BOTH BEFORE AND AFTER A HEART FAILURE HOSPITALIZATION
Authors: Jerard Kneifati-Hayek, Alexi Archambault, Krisha Mehta, Ligong Chen, Ivan Diaz, Joseph Hanlon, Emily Levitan, Mark Lachs, Mathew Maurer, Monika Safford, Parag Goyal
Journal: Journal of the American College of Cardiology (2019)
Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study
Authors: Byoung Chul Cho, Radka Obermannova, Alessandra Bearz, Mark McKeage, Dong-Wang Kim, Ullas Batra, Gloria Borra, Sergey Orlov, Sang-We Kim, Sarayut L. Geater, Pieter E. Postmus, Scott A. Laurie, Keunchil Park, Cheng-Ta Yang, Andrea Ardizzoni, Anna C. Bettini, Gilberto de Castro, Flavia Kiertsman, Zhe Chen, Yvonne Y. Lau, Kalyanee Viraswami-Appanna, Vanessa Q. Passos, Rafal Dziadziuszko
Journal: Journal of Thoracic Oncology (2019)

In an earlier report of the ASCEND-8 study (open-label, phase I, three-arm study, treatment-naive patients and pre-treated patients with advanced/metastatic NSCLC), it was shown that ceritinib 450 mg with food had comparable exposure and better gastrointestinal tolerability than 750-mg fasted.Here, we report efficacy and updated safety data from primary efficacy analysis of the ASCEND-8 study. Key secondary endpoints were overall response rate and duration of response, assessed by blinded independent review committee (BIRC) using Response Evaluation Criteria in Solid Tumors 1.1.In total, 306 patients were randomized to ceritinib 450-mg fed (n = 108) or 600-mg fed (n = 87) or 750-mg fasted (n = 111), of which 304 patients were included in safety analysis and 198 treatment-naive patients (ALK receptor tyrosine kinase [ALK]-positive by immunohistochemistry) were included in the efficacy analysis (450-mg fed [n = 73], 600-mg fed [n = 51], and 750-mg fasted [n = 74]). The BIRC-assessed overall response rate was 78.1% (95% confidence interval [CI]: 66.9-86.9), 72.5% (95% CI: 58.3-84.1), and 75.7% (95% CI: 64.3-84.9), respectively; and the median duration of response (months) by BIRC was not estimable (NE) (95% CI: 11.2-NE), 20.7 (95% CI: 15.8-NE), and 15.4 (95% CI: 8.3-NE), respectively. Based on the safety analysis (n = 304), the 450-mg fed arm showed the highest median relative dose intensity (100% versus 78.5% versus 83.7%), lowest proportion of patients with dose reductions (24.1% versus 65.1% versus 60.9%), and lowest proportion of patients with gastrointestinal toxicities (75.9% versus 82.6% versus 91.8%).Ceritinib at a dose of 450 mg with food compared to 750-mg fasted showed consistent efficacy and less gastrointestinal toxicity.
PREVALENCE OF THIN CAP FIBROATHEROMA AND PLAQUE RUPTURE IN RELATION TO THE PHYSIOLOGICAL STENOSIS SEVERITY DETERMINED BY FRACTIONAL FLOW RESERVE AND CORONARY FLOW RESERVE
Authors: Masahiro Hoshino, Yoshihisa Kanaji, Akinori Sugano, Masao Yamaguchi, Masahiro Hada, Yohei Sumino, Hiroaki Ohya, Yoshinori Kanno, Hidenori Hirano, Haruhito Yuki, Tomoki Horie, Taishi Yonetsu, Tsunekazu Kakuta
Journal: Journal of the American College of Cardiology (2019)
Philippines to charge Sanofi staff and government officials over dengue vaccine
Authors: Owen Dyer
Journal: BMJ (2019)

Philippine government prosecutors who investigated an aborted school immunisation campaign with Sanofi Pasteur’s dengue vaccine Dengvaxia have found probable cause for criminal indictment in Sanofi staff and government officials.

A total of 20 people will face a charge of reckless imprudence resulting in homicide relating to the deaths of 10 children, the Philippine Department of Justice announced.1 This includes a former health secretary, nine health department officials, officials of the country’s Food and Drug Administration and its Research Institute for Tropical Medicine, and six Sanofi employees.

Prosecutors allege that officials and regulators rushed to approve and buy the vaccine when it had not completed clinical trials, then allowed unqualified personnel to administer it. Sanofi staff are accused of failing to monitor the programme or assist families when adverse events were …
GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors
Authors: Johanna Chiche, Julie Reverso-Meinietti, Annabelle Mouchotte, Camila Rubio-Patiño, Rana Mhaidly, Elodie Villa, Jozef P. Bossowski, Emma Proics, Manuel Grima-Reyes, Agnès Paquet, Konstantina Fragaki, Sandrine Marchetti, Josette Briere, Damien Ambrosetti, Jean-François Michiels, Thierry Jo Molina, Christiane Copie-Bergman, Jacqueline Lehmann-Che, Isabelle Peyrottes, Frederic Peyrade, Eric de Kerviler, Bruno Taillan, Georges Garnier, Els Verhoeyen, Véronique Paquis-Flucklinger, Laetitia Shintu, Vincent Delwail, Celine Delpech-Debiais, Richard Delarue, André Bosly, Tony Petrella, Gabriel Brisou, Bertrand Nadel, Pascal Barbry, Nicolas Mounier, Catherine Thieblemont, Jean-Ehrland Ricci
Journal: Cell Metabolism (2019)
Abstract 576: Nrf2 is a Key Regulator on Puerarin Preventing Cardiac Hypertrophy and Upregulating Metabolic Enzymes Ugt1a1 and Ugt1a9 in Rats
Authors: Ning Hou, Ganjian Zhao, Shaoai Cai, Xiawen Liu, Aiqun Li, Yin Huang, Lirong Li, Chengfeng Luo
Journal: Circulation Research (2018)

Previous evidence suggested that puerarin may attenuate cardiac hypertrophy; however, the potential mechanisms were undetermined. Moreover, the use of puerarin is limited by severe adverse events, including intravascular hemolysis. This study used a rat model of abdominal aortic constriction (AAC) -induced cardiac hypertrophy to evaluate the potential mechanisms underlying the attenuating efficacy of puerarin on cardiac hypertrophy as well as the metabolic mechanisms of puerarin involved. We confirmed that puerarin (50 mg/kg/d) significantly attenuated cardiac hypertrophy, upregulated Nrf2 and decreased Keap1 in the myocardium. Moreover, puerarin significantly promoted Nrf2 translocation to the nucleus in parallel with the upregulated downstream proteins including heme oxygenase-1, glutathione s-transferase p-1 and NAD(P)H: quinone oxidoreductase-1. Similar results were obtained in neonatal rat cardiomyocytes (NRCMs) treated with angiotensin II (1 μM) and puerarin (100 μM), while the silencing of Nrf2 abolished the antihypertrophic effects of puerarin. The mRNA and protein levels of UGT1A1 and UGT1A9, enzymes for puerarin metabolism, were significantly increased in the liver and heart tissues of AAC rats and angiotensin II-treated NRCMs. Interestingly, the silencing of Nrf2 attenuated the puerarin-induced upregulation of UGT1A1 and UGT1A9. The results of chromatin immunoprecipitation-qPCR indicated that the binding of Nrf2 to the promoter region of UGT1A1 or UGT1A9 was significantly enhanced in puerarin-treated cardiomyocytes. These results suggest that Nrf2 is the key regulator of antihypertrophic effects and the upregulation of the metabolic enzymes UGT1A1 and UGT1A9 of puerarin. This autoregulatory circuits between puerarin and Nrf2-induced UGT1A1/1A9 are beneficial to attenuate adverse effects and maintain the pharmacological effects of puerarin.
Abstract A15: Oncomirs expression profiling in uterine leiomyosarcoma cells
Authors: Bruna Cristine De Almeida, Natalia Garcia, Edmund Chada Baracat, Kátia Candido Carvalho
Journal: Clinical Cancer Research (2018)

Abstract miRNAs act as regulators of gene expression at the post-transcriptional level, playing a key role in several biologic processes; their abnormal expression may to lead a cellular transformation and tumorigenesis. miRNAs are considered as oncomirs when regulated oncogenes or tumor suppressor genes. Here, we aimed to evaluate the expression profile of 84 oncomirs sequences in immortalized cells of myometrium (MM), uterine leiomyoma (ULM), and uterine leiomyosarcoma (ULMS), seeking specific signatures for these cells. MM (PCS-460-011), LM (T HESCs CRL-4003) and ULMS (SK-UT-1 HTB-114) cells line were cultured in specific medium and conditions (ATCC recommendations). Quantitative Real Time - PCR was performed using the MIHS-109ZA-Qiagen 96 wells plate; all data were normalized and analyzed by ΔΔCt method in the pcrdataanalysis.sabiosciences.com/mirna software. Data analysis showed nine miRNAs with significant differential expression in ULM and fifteen in ULMS, using MM cells as reference. Six miRNAs were overexpressed in ULM;among them two had a high fold regulation (miR-205-5p and miR-328-3p). In ULMS six miRNAs exhibited a significant overexpression, with greater fold regulation in miR-148a-3p, miR-202-3p, and miR-203a-3p. We found nine downregulated miRNAs in ULMS and four in ULM. A reverse expression was observed in miR-21-5p and miR-27b-3p in ULM and ULMS; in addition, these miRNAs showed a downregulation in ULMS with high fold regulation. miR-495-3p, miR-27b-3p, and miR-152-3p had a significant downregulated expression in ULMS. Only two miRNAs (miR-31-5p and miR-210-3p) showed downregulated expression in ULM than ULMS. In conclusion, our preliminary approach identified 17 oncomirs with a significantly deregulated expression profile in ULM and ULMS that might lead to alterations in their mRNA-target. Their role in ULM and ULMS may be further investigated. Citation Format: Bruna Cristine De Almeida, Natalia Garcia, Edmund Chada Baracat, Kátia Candido Carvalho. Oncomirs expression profiling in uterine leiomyosarcoma cells [abstract]. In: Proceedings of the AACR International Conference held in cooperation with the Latin American Cooperative Oncology Group (LACOG) on Translational Cancer Medicine; May 4-6, 2017; São Paulo, Brazil. Philadelphia (PA): AACR; Clin Cancer Res 2018;24(1_Suppl):Abstract nr A15.
Fractures in Elderly Americans Associated With Walking Leashed Dogs
Authors: Kevin Pirruccio, Yeo Myoung Yoon, Jaimo Ahn
Journal: JAMA Surgery (2019)

Fractures in Elderly Americans Associated With Walking Leashed DogsDog walking is often suggested as an effective modality for improving physical health in elderly Americans. 1 Nonetheless, injury risks associated with dog walking remain obscure.Considering that older patients are more vulnerable to fractures owing to falls or axial muscle compression forces inherent to walking motions, a risk-benefit analysis with respect to dog walking as an exercise alternative is essential to minimizing injury risk. 2 This study represents a comprehensive, up-todate investigation into fracture risk in older adults who use leashes when walking dogs.
ASSOCIATION BETWEEN GUIDELINE-DIRECTED MEDICAL THERAPIES FOR COMORBID CONDITIONS AND CLINICAL OUTCOMES AMONG INDIVIDUALS WITH ATRIAL FIBRILLATION
Authors: Zak Loring, Peter Shrader, Larry Allen, Rosalia Blanco, Paul Chan, Michael Ezekowitz, Gregg Fonarow, James Freeman, Bernard Gersh, Kenneth Mahaffey, Gerald Naccarelli, Karen Pieper, James Reiffel, Daniel Singer, Benjamin Steinberg, Eric Peterson, Jonathan Piccini
Journal: Journal of the American College of Cardiology (2019)
ANGIOTENSIN CONVERTING ENZYME INHIBITOR REDUCES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS: A RETROSPECTIVE COHORT STUDY FROM THE TREATMENT OF PRESERVED CARDIAC FUNCTION HEART FAILURE WITH AN ALDOSTERONE ANTAGONIST TRIAL
Authors: Tran Nguyen, Talal Alzahrani, James McCaffery, Raza Yunus, Adebayo Atanda, Marco Mercader, Allen Solomon
Journal: Journal of the American College of Cardiology (2019)
Scotland needs 82 extra paediatricians to deliver safe care, college warns
Authors: Bryan Christie
Journal: BMJ (2019)

Children’s health in Scotland is being placed at risk because the country has too few doctors to deliver the necessary standards of care, the Royal College of Paediatrics and Child Health has warned.

Its workforce survey concluded that Scotland needs at least 82 additional full time consultant paediatricians—a 25% increase—to bring the service up to an acceptable standard.1

Pressures on the service led to inpatient paediatric units in Scotland having to be closed to new patients for 137 days in total in …
THIRTY-DAY READMISSIONS AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE MYOCARDIAL INFARCTION COMPLICATING CARDIOGENIC SHOCK
Authors: Varunsiri Atti, Nileshkumar Patel, Byomesh Tripathi, Varun Kumar, Mir Basir, Annapoorna Kini, Samin Sharma, William O'Neill
Journal: Journal of the American College of Cardiology (2019)
PREOPERATIVE BIOMARKERS TO PREDICT POSTOPERATIVE OUTCOMES IN CHILDREN: SERUM NT-PROBNP IS ELEVATED IN PATIENTS WITH POSTOPERATIVE ARRHYTHMIAS FOLLOWING CONGENITAL HEART SURGERY
Authors: Jeffrey Weiner, Kimberly Crum, Sara Van Driest, Andrew H. Smith, Thomas Wang, Prince Kannankeril
Journal: Journal of the American College of Cardiology (2019)
IS AN ISOLATED ST SEGMENT ELEVATION IN LEAD AVR ASSOCIATED WITH HIGH GRADE CORONARY ARTERY DISEASE? SYSTEMATIC REVIEW
Authors: Amit Alam, Ammar Al Akshar, Emily Hiltner, Haroon Kamran, Kleanthis Theodoropoulos, Prachi Thanawali, Abdul Hakeem, John Kassotis
Journal: Journal of the American College of Cardiology (2019)
CHANGE IN CIRCULATING PROGENITOR CELLS DURING STRESS TESTING AND RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE
Authors: Kasra Moazzami, Bruno Lima, Muhammad Hammadah, Ayman Alkhoder, Iraj Ghaini, Oleksiy Levantsevych, Amit Shah, Doug Bremner, Jonathan Kim, Edmund Waller, Viola Vaccarino, Arshed Quyyumi
Journal: Journal of the American College of Cardiology (2019)